Tumor necrosis factor alpha (TNF-α) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia

Natural Killer cells contribute to mitochondrial dysfunction in response to placental ischemia in Reduced Uterine Perfusion Pressure (RUPP) rats.

(2019) Venkata Ramana Vaka et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Blockade of endogenous Angiotensin II type I receptor agonistic autoantibody activity improves mitochondria reactive oxygen species and hypertension in a rat model of Preeclampsia

(2019) Venkata Ramana Vaka et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic RatsNovelty and Significance

(2018) Mark W. Cunningham et al.   HYPERTENSION

Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia

(2018) Venkata Ramana Vaka et al.   HYPERTENSION

Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy

(2018) Mark W. Cunningham et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

Identifying immune mechanisms mediating the hypertension during preeclampsia

(2016) Babbette LaMarca et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia

(2016) Babbette LaMarca et al.   CURRENT HYPERTENSION REPORTS

Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II–Induced Renal Vascular Sensitivity and Reduce Renal Function During PregnancyNovelty and Significance

(2016) Mark W. Cunningham et al.   HYPERTENSION

Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment

(2014) P. Conigliaro et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease

(2013) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

(2013) Ole Haagen Nielsen et al.   BMC Medicine

Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study

(2013) Orna Diav-Citrin et al.   REPRODUCTIVE TOXICOLOGY

Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α

(2012) Sydney R. Murphy et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade

(2011) Jolanta Gutkowska et al.   JOURNAL OF HYPERTENSION

The Effect of Immune Factors, Tumor Necrosis Factor- , and Agonistic Autoantibodies to the Angiotensin II Type I Receptor on Soluble fms-Like Tyrosine-1 and Soluble Endoglin Production in Response to Hypertension During Pregnancy

(2010) M. R. Parrish et al.   AMERICAN JOURNAL OF HYPERTENSION

Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases

(2009) Nádia Emi Aikawa et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Autoantibodies to the Angiotensin Type I Receptor in Response to Placental Ischemia and Tumor Necrosis Factor α in Pregnant Rats

(2008) Babbette LaMarca et al.   HYPERTENSION

Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats

(2008) Babbette LaMarca et al.   HYPERTENSION